The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Antibody-interferon-alpha fusion protein (IGN002) for the treatment of b-cell non-Hodgkin lymphomas: A phase 1, first-in-human, dose-escalation trial.
 
Patricia Ann Young
No Relationships to Disclose
 
Nam H. Dang
No Relationships to Disclose
 
Loretta J. Nastoupil
Honoraria - Celgene; Genentech/Roche
Research Funding - Abbvie; Janssen Biotech; TG Therapeutics
Travel, Accommodations, Expenses - Janssen Biotech
 
Dena Minning
Employment - ImmunGene; Valor Biotherapeutics
Stock and Other Ownership Interests - ImmunGene
Travel, Accommodations, Expenses - ImmunGene
 
Michael J. Gresser
Employment - ImmunGene; Valor Biotherapeutics
Leadership - ImmunGene
Stock and Other Ownership Interests - ImmunGene
Travel, Accommodations, Expenses - ImmunGene; Valor Biotherapeutics
 
John Timmerman
Stock and Other Ownership Interests - Biomarin; Medivation
Honoraria - Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb; ImmunGene; Janssen Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb